Clinical Trial Update: Digoxin Versus Ivabradine in Heart Failure With Reduced Ejection Fraction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing digoxin with ivabradine in heart failure with reduced ejection fraction; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• DIGOXIN (Digoxin)
• IVABRADINE

Snippet

Sponsor: Kocaeli University | Conditions: Heart Failure | Phase 4 | Status: UNKNOWN